Heart block and temporary pacing during rotational atherectomy

Michael D Mitar1, Shemer Ratner1, Shahar Lavi1

  • 1London Health Sciences Centre and Western University, London, Ontario, Canada.

Insights

Temporary pacing is often used during rotational atherectomy (RA) due to conduction abnormalities. This study found heart block or pacing activation was more common with RA to the right coronary artery and left-dominant circumflex arteries, suggesting prophylactic pacing may be avoidable in other cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Electrophysiology

Background:

  • Rotational atherectomy (RA) during percutaneous coronary intervention can cause distal embolization, leading to conduction abnormalities and frequent use of temporary pacing.
  • The necessity of routine temporary pacing during RA remains unclear.

Purpose of the Study:

  • To investigate the incidence and predictors of intraprocedural heart block or pacemaker activation during rotational atherectomy.
  • To determine if prophylactic temporary pacing can be avoided in certain cases.

Main Methods:

  • Retrospective analysis of 134 consecutive patients undergoing RA between January 2011 and September 2013.
  • Evaluation of intraprocedural heart block or pacemaker activation.
  • Multivariate analysis to identify associated factors, including target vessel.

Main Results:

  • Temporary pacemaker insertion occurred in 50% of patients; 31% experienced heart block or pacemaker activation.
  • No significant differences in baseline or interventional characteristics were found between patients with and without heart block/pacing.
  • Target vessel was the only significant predictor: RA to the right coronary artery (53%) and left-dominant circumflex artery (62%) were associated with higher rates of heart block or pacing activation.

Conclusions:

  • Heart block or temporary pacing during RA is significantly associated with lesions in the right coronary artery and left-dominant circumflex artery.
  • Prophylactic pacemaker insertion may be safely avoided when performing RA on other coronary vessels.
Abstract

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
845
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.4K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
637
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.4K